Discount program: 5% OFF for the second order, 7% OFF for the third order.
Shop with us securely! We offer re-shipment guarantees.
We always provide new, legal products of impeccable quality.
Please make sure that the product is legal in your country and not under any restrictions before ordering.
We do not sell pharmaceutical products or controlled substances.
What is 3-Hydroxyeticyclidine (3-HO-PCE)?
3-Hydroxyeticyclidine, often known as 3-HO-PCE, is a new dissociative drug that has gained interest as a study molecule in recent years. This arylcyclohexylamine molecule causes significant dissociative, hallucinogenic, and euphoric effects, making it a desirable chemical for those trying to alter their mental state. However, despite the drug's increasing popularity, there is a shortage of information on it, making it difficult for users to comprehend its possible hazards and side effects. This page aims to offer a complete overview of 3-HO-PCE, including its effects, hazards, and current knowledge.
Effects of 3-Hydroxyeticyclidine (3-HO-PCE)
The effects of 3-HO-PCE are dose-dependent; however, it is typically regarded as a solid dissociative, hallucinogenic, and euphoric drug. It is supposed to cause an altered state of consciousness characterized by a sensation of detachment from the body and the physical world. Some users claim dramatic visual and aural hallucinations, while others report extreme exhilaration and heightened perception. However, these effects might be unexpected and vary considerably from person to person.
Risks of 3-Hydroxyeticyclidine (3-HO-PCE)
3-HO-PCE, like all other research compounds, is connected with multiple dangers and adverse consequences. As with any drug, the likelihood of adverse effects increases with increasing dosages. Anxiety, paranoia, disorientation, and psychological side effects are among the potential hazards of 3-HO-PCE. In addition, bodily injury is dangerous, such as convulsions, high blood pressure and heart rate, and other cardiovascular side effects.
Affinity for the μ-Opioid Receptor
Given its structural similarity to 3-HO-PCP, which has been found to exhibit affinity for the -opioid receptor in animal models, one of the earliest discussions over 3-HO-PCE centred on whether it had a substantial affinity for this receptor. Whether 3-HO-PCE causes any of its hypothesized opioid effects in people is the topic of ongoing debate. Still, if it does, it may represent distinct hazards compared to other dissociatives, significantly when reduced.
To prepare the content, the following materials were used:
Substance Registration System
Hazardous Substances Data Bank. National Library of Medicine. 28
August 2008. Retrieved 22 August 2014. 3,4-Methylenedioxymethamphetamine
Liver transplant modulates gut microbial dysbiosis and cognitive
function in cirrhosis. PDF . By HoChong Gilles, Scott C Matherly, Mohammed S
Siddiqui, Puneet Puri...
Differential impact of hyponatremia and hepatic encephalopathy on
health-related quality of life and brain metabolite abnormalities in cirrhosis .
By Jasmohan Bajaj
An overview of alcohol and other drug issues
Medicating the mind: a Kantian analysis of overprescribing
psychoactive drugs B A Manninen
pharmacological basis of opioids Carla Ghelardini, Lorenzo Di Cesare Mannelli
and Enrica Bianchi
- Ask Dr. Shulgin Online ARCHIVE: June 3, 2004
Inhibition of plasma membrane monoamine transporters by
β-ketoamphetamines. Nicholas V Cozzi, Michael KSievert, Alexander T Shulgin,
Peyton JacobIII, Arnold Eruoho
Schedules of Controlled Substances: Placement of Methylone Into
of new designer drugs. Wohlfarth A, Weinmann W.
- New Psychoactive Substances (including synthetic cannabinoids,
mephedrone, and more)
Future Synthetic Drugs of Abuse. Donald A. Cooper. Drug
Enforcement Administration McLean, Virginia
Designer drugs: a medicinal chemistry perspective. F. Ivy Carroll
Anita H. Lewin S. Wayne Mascarella Herbert H. Seltzman P. Anantha Reddy
- Synthetic cannabinoids in Europe
- Pharmacological Effects of MDMA in Man. By Enno Freye
Drug Use in Relation to Outcome of Mammography Screening. von
Euler-Chelpin M, Wu W, Vejborg and Lynge E
- DEA Drug
Effects of Trace Amines on Mesencephalic Dopaminergic Neurons.Ada Ledonne,
Nicola Berretta, Alessandro Davoli, Giada Ricciardo Rizzo, Giorgio Bernardi and
Nicola Biagio Mercuri
evidence for a reciprocal interaction between amphetamine and cocaine-related
drugs on rat midbrain dopaminergic neurons.Scarponi M, Bernardi G, Mercuri
- Overdose of Drugs for Attention-Deficit Hyperactivity Disorder:
Clinical Presentation, Mechanisms of Toxicity, and Management. Henry A. Spiller,
author Hannah L. Hays Alfred Aleguas.
effectiveness of wheel running to attenuate cocaine-seeking: impact of sex and
estrous cycle in rats. Peterson AB, Hivick DP, Lynch WJ.r.
Drug Safety Communication: Safety Review Update of Medications used to treat
Attention-Deficit/Hyperactivity Disorder (ADHD) in children and young adults
Medications and Risk of Serious Cardiovascular Events in Young and Middle-aged
Controlled Substances Act
The Art of Drug Synthesis (Wiley Series on Drug Synthesis)
- Cannabis: domestic cultivation widespread
- A review of
the influence of functional group modifications to the core scaffold of
synthetic cathinones on drug pharmacokinetics